As COVID-19 cases in China continue to expand, the country’s medical products regulator has approved trials for a new combination treatment using both a Chinese and an American vaccine. Meanwhile, Sinovac has reported a third dose of its vaccine seems to give substantial benefits to older recipients. The World Health Organization approved the SinoVac vaccine for emergency use in June, enabling the shot to join China’s other major vaccine by Sinopharm in being exported. According to Caixin Global, by the end of June, China had exported 500 million vaccines abroad, the vast majority of them to Africa and Asia. The two continents are largely unable to purchase expensive vaccines made by pharmaceutical giants like Pfizer and Moderna.

Source: The Nation August 11, 2021 04:18 UTC